Cargando…
Loureirin B activates GLP‐1R and promotes insulin secretion in Ins‐1 cells
Loureirin B (LB) is a natural product derived from Sanguis draconis, which has hypoglycaemic effects. In order to research the possible target of LB in the treatment of diabetes, molecular docking was used to simulate the interaction between LB and potential targets, and among them, glucagon‐like pe...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7812269/ https://www.ncbi.nlm.nih.gov/pubmed/33300675 http://dx.doi.org/10.1111/jcmm.16138 |